Status:
COMPLETED
Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty
Lead Sponsor:
Mayo Clinic
Conditions:
Total Joint Arthroplasty
Eligibility:
All Genders
18+ years
Brief Summary
This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.
Eligibility Criteria
Inclusion
- Adult patients age ≥ 18.
- Undergoing either primary total knee or total hip arthroplasty for a primary underlying diagnosis of osteoarthritis.
Exclusion
- \- Individuals \< 18 years of age.
Key Trial Info
Start Date :
June 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05369325
Start Date
June 15 2022
End Date
July 1 2023
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905